Business Standard

Monday, December 23, 2024 | 01:37 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Marksans Pharma receives UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution

Image

Capital Market
Marksans Pharma announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.

Therapeutic use of the product is for treatment of depressive illness and other mental/mood disorders.

The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) located at Gifford House, Slaidburn Crescent, Southport, UK.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 23 2023 | 1:41 PM IST

Explore News